Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2017
Title: Josicelli Souza Crispim: Innovator in Vaccine Development
Introduction
Josicelli Souza Crispim is a notable inventor based in Viçosa, Brazil. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for swine. His innovative work focuses on combating diseases associated with porcine circovirus 2 (PCV-2).
Latest Patents
Crispim holds a patent for "Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof." This invention pertains to the preparation of recombinant antigens derived from the viral capsid of PCV-2. The process involves expression in a prokaryotic system, purification in monomer form, and recovery of virus-like particles (VLPs). These antigens are utilized in vaccine formulations and diagnostic kits, providing alternatives to existing commercial vaccines. Additionally, the ELISA kit developed can assess the quality of both commercial and experimental vaccines against PCV-2.
Career Highlights
Throughout his career, Josicelli Souza Crispim has worked with esteemed institutions such as the Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and the Universidade Federal de Viçosa. His research has significantly impacted the field of veterinary immunology, particularly in swine breeding systems.
Collaborations
Crispim has collaborated with notable colleagues, including Márcia Rogéria de Almeida and Abelardo Silva Junior. These partnerships have enhanced the scope and impact of his research in vaccine development.
Conclusion
Josicelli Souza Crispim's contributions to vaccine innovation for porcine circovirus 2 highlight his role as a key figure in veterinary medicine. His work not only advances scientific knowledge but also provides practical solutions for swine health management.